Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIPEL.L Regulatory News (IPEL)

  • There is currently no data for IPEL

Trading Statement

21 Oct 2010 07:00

RNS Number : 7190U
Impellam Group plc
21 October 2010
 



Impellam Group plc

("Impellam", the "Company" or the "Group")

 

Trading Update

 

On 6 August 2010 the Company announced its unaudited interim results for the 26 weeks ended 2 July 2010 which stated that operating profit had increased to £12.5m (2009 £0.5m). Net debt had decreased by £30.4 million to £39.2 million as at 2 July 2010 as a result of significant cash generation for the period.

 

Since the interim period end, Impellam has continued to see improved operating performance consistent with the trends experienced during the first half of the year. Net debt stands at £28.5m at 1 October 2010.

 

Cheryl Jones, Chairman, commented:

 

"For the trading period following the Groups half year end, the Company has seen operating performance improvement consistent with that experienced during the first half of the year. Efficiency programs and business rationalization have continued across the Group, and the Company continues to prioritize key drivers of our plan which include leveraging our brands, further improving our process and technology environments, investing in service innovation and refining our growth strategy."

 

 

Enquiries: For any further information please contact:

Impellam Group plc

Cheryl Jones, Chairman

Andrew Burchall, Group Finance Director

Tel: 01582 692658

Tel: 01582 692658

Cenkos Securities plc (Nominated Advisor and Broker to Impellam)

Nicholas Wells

Elizabeth Bowman

Tel: 020 7397 8900

Tel: 020 7397 8900

 

 

Note to Editors:

Impellam is traded on AIM (Symbol: IPEL) and is a leading provider of staffing solutions, human capital management and outsourced people-related services with established operations in the UK, Ireland, USA, mainland Europe, Australia and New Zealand.

 

Business Segment

Staffing Sectors/Brands

Healthcare Staffing

The Group's Healthcare staffing segment comprises Medacs Healthcare (locum doctors, nursing, international recruitment and managed healthcare services) and Chrysalis Homecare (domiciliary care).

UK Staffing - Commercial

 

The Group's UK Commercial staffing segment primarily includes those brands that operate in the traditional clerical, administrative, industrial/trades and hospitality staffing markets. These principal brands include ABC Contract Services (construction and telecoms), Blue Arrow (catering, managed services, office and industrial), Carlisle Managed Solutions (managed services), Comensura (vendor neutral staffing & recruitment procurement), and Tate (office).

UK Staffing - Professional & Technical

 

The Group's UK Professional & Technical staffing segment comprises the following principal brands: Austin Benn (sales and marketing), Celsian Education (teachers and school support staff), Chadwick Nott (legal), Hewitson Walker (accounting), IRC (multi-sector staffing in Ireland), S∙COM (technical) and SRG (scientific).

US Staffing

The Group's US staffing segment operates across a wide spectrum of staffing sectors. The principal brands and their specialties include CORESTAFF Services and Leafstone (Call centre/customer care, engineering, IT, light industrial, office/clerical, professional, skilled trade and technical), Guidant Group (managed services), InfoCurrent (information/records management and library services), S∙COM (technical and telecom) and SRG Woolf (clinical research).

Support Services

The Group's Support services segment consists of several brands providing a wide range of outsourced services to clients throughout the UK. These brands include Carlisle Cleaning & Support Services (contract cleaning and facility support services), Carlisle Security (security guarding and CCTV public space surveillance), and the Recruit (retail merchandising and events).

 

- END-

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTXBLFLBBFLFBE
Date   Source Headline
9th Jan 202310:44 amRNSForm 8.5 (EPT/RI)
9th Jan 202310:31 amRNSRule 2.9 Announcement
9th Jan 202310:30 amRNSTransaction in Own Shares
6th Jan 202312:04 pmRNSForm 8.3 - Impellam Group PLC
6th Jan 202310:30 amRNSForm 8.5 (EPT/RI)
5th Jan 20232:33 pmRNSForm 8.3 - Impellam Group PLC
5th Jan 20239:16 amRNSForm 8.5 (EPT/RI) - Impellam Group plc
4th Jan 20231:31 pmRNSForm 8.3 - Impellam Group PLC
4th Jan 20238:22 amRNSForm 8.5 (EPT/RI)
3rd Jan 20237:00 amRNSForm 8.3 - Impellam Group Plc
30th Dec 202210:01 amRNSForm 8.3 - Impellam Group PLC
29th Dec 202211:10 amRNSForm 8.5 (EPT/RI) - Impellam Group plc
29th Dec 20229:53 amRNSForm 8.3 - Impellam Group PLC
28th Dec 202210:51 amRNSForm 8.5 (EPT/RI)
23rd Dec 20229:37 amRNSForm 8.5 (EPT/RI)
22nd Dec 20227:00 amRNSSpecial Dividend Declaration
14th Dec 20222:55 pmRNSRule 2.9 Announcement
14th Dec 20222:30 pmRNSTransaction in Own Shares
14th Dec 20227:28 amRNSForm 8.5 (EPT/RI)
12th Dec 202210:00 amRNSRule 2.9 Announcement
12th Dec 202210:00 amRNSTransaction in Own Shares
12th Dec 20227:48 amRNSForm 8.5 (EPT/RI)
9th Dec 202211:03 amRNSForm 8.5 (EPT/RI)
8th Dec 202211:25 amRNSForm 8.5 (EPT/RI) - Impellam Group plc
6th Dec 20229:51 amRNSForm 8.5 (EPT/RI)
6th Dec 20227:00 amRNSRule 2.9 Announcement
6th Dec 20227:00 amRNSTransaction in Own Shares
2nd Dec 20224:02 pmRNSRule 2.9 Announcement
2nd Dec 20224:01 pmRNSTransaction in Own Shares
2nd Dec 20227:00 amRNSForm 8.5 (EPT/RI)
1st Dec 202212:01 pmRNSRule 2.9 Announcement
1st Dec 202212:00 pmRNSTransaction in Own Shares
1st Dec 202210:02 amRNSForm 8.5 (EPT/RI)
30th Nov 20227:31 amRNSForm 8.5 (EPT/RI)
30th Nov 20227:01 amRNSRule 2.9 Announcement
30th Nov 20227:00 amRNSTransaction in Own Shares
29th Nov 20227:00 amRNSForm 8.5 (EPT/RI)
28th Nov 202211:01 amRNSForm 8.5 (EPT/RI)
28th Nov 20229:00 amRNSRule 2.9 Announcement
28th Nov 20229:00 amRNSTransaction in Own Shares
25th Nov 20229:05 amRNSForm 8.5 (EPT/RI)
23rd Nov 202210:46 amRNSRule 2.9 Announcement
23rd Nov 202210:45 amRNSTransaction in Own Shares
23rd Nov 202210:13 amRNSForm 8.5 (EPT/RI)
22nd Nov 20229:16 amRNSRule 2.9 Announcement
22nd Nov 20229:15 amRNSTransaction in Own Shares
22nd Nov 20228:03 amRNSForm 8.5 (EPT/RI)
21st Nov 202210:45 amRNSForm 8.5 (EPT/RI)
21st Nov 20227:01 amRNSRule 2.9 Announcement
21st Nov 20227:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.